NO983580L - 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav - Google Patents

5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav

Info

Publication number
NO983580L
NO983580L NO983580A NO983580A NO983580L NO 983580 L NO983580 L NO 983580L NO 983580 A NO983580 A NO 983580A NO 983580 A NO983580 A NO 983580A NO 983580 L NO983580 L NO 983580L
Authority
NO
Norway
Prior art keywords
preparation
alpha
oral administration
reductase inhibitor
formulation
Prior art date
Application number
NO983580A
Other languages
English (en)
Other versions
NO983580D0 (no
Inventor
Fusao Usui
Yuko Ohuchi
Akira Kusai
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO983580D0 publication Critical patent/NO983580D0/no
Publication of NO983580L publication Critical patent/NO983580L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO983580A 1996-02-05 1998-08-04 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav NO983580L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1871896 1996-02-05
PCT/JP1997/000273 WO1997027875A1 (fr) 1996-02-05 1997-02-04 PREPARATION INHIBITRICE DE LA 5α-REDUCTASE ADMINISTRABLE PAR VOIE ORALE, PROCEDE DE PRODUCTION ET UTILISATION

Publications (2)

Publication Number Publication Date
NO983580D0 NO983580D0 (no) 1998-08-04
NO983580L true NO983580L (no) 1998-10-02

Family

ID=11979447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983580A NO983580L (no) 1996-02-05 1998-08-04 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav

Country Status (18)

Country Link
US (1) US20020015732A1 (no)
EP (1) EP0923942B1 (no)
KR (1) KR19990082277A (no)
CN (1) CN1215339A (no)
AT (1) ATE208631T1 (no)
AU (1) AU709146B2 (no)
CZ (1) CZ289856B6 (no)
DE (1) DE69708307T2 (no)
DK (1) DK0923942T3 (no)
ES (1) ES2165017T3 (no)
HK (1) HK1020258A1 (no)
HU (1) HUP9901870A3 (no)
MX (1) MX9806292A (no)
NO (1) NO983580L (no)
NZ (1) NZ326897A (no)
PT (1) PT923942E (no)
RU (1) RU2154467C2 (no)
WO (1) WO1997027875A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT963998E (pt) * 1997-02-26 2004-07-30 Sankyo Co Composicoes para tratar ou prevenir cancro prostatico
ID24566A (id) * 1997-07-29 2000-07-27 Sankyo Co Obat untuk alopesia
CN110643557B (zh) * 2019-04-23 2021-12-31 天津科技大学 一种基因工程菌的构建及其在高效催化5α-雄烯二酮生产中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
ZA851426B (en) * 1984-02-27 1986-10-29 Merck & Co Inc 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JPH06293793A (ja) * 1993-02-10 1994-10-21 Sankyo Co Ltd ステロイド−１７−アミド類の製造法

Also Published As

Publication number Publication date
HK1020258A1 (en) 2000-04-07
US20020015732A1 (en) 2002-02-07
WO1997027875A1 (fr) 1997-08-07
NZ326897A (en) 1999-08-30
DE69708307D1 (de) 2001-12-20
EP0923942B1 (en) 2001-11-14
MX9806292A (es) 1998-11-30
AU709146B2 (en) 1999-08-19
AU1558997A (en) 1997-08-22
RU2154467C2 (ru) 2000-08-20
EP0923942A4 (no) 1999-06-23
KR19990082277A (ko) 1999-11-25
CZ234298A3 (cs) 1998-11-11
HUP9901870A3 (en) 1999-11-29
PT923942E (pt) 2002-03-28
HUP9901870A2 (hu) 1999-09-28
ATE208631T1 (de) 2001-11-15
ES2165017T3 (es) 2002-03-01
DK0923942T3 (da) 2001-12-17
EP0923942A1 (en) 1999-06-23
NO983580D0 (no) 1998-08-04
CN1215339A (zh) 1999-04-28
CZ289856B6 (cs) 2002-04-17
DE69708307T2 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
DK1110542T3 (da) Oral metoprololdoseringsform til anvendelse én gang om dagen
AU2002316811A1 (en) Stable formulation of modified glp-1
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
GB2341801B (en) Formulation
DK0700284T3 (da) Oxybutyninformuleringer med kontrolleret frigivelse
DK0730444T3 (da) Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
EP0931788A3 (en) Metalloprotease inhibitors
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
HUP9802999A2 (hu) N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény
DE59000750D1 (de) Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate.
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
DE69320339T2 (de) Derivate des Dolastatin
NO983580L (no) 5&lt;alfa&gt;-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
EA200000112A1 (ru) Новая композиция
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
DK0835656T3 (da) Kombinationspræparat indeholdende tramadol og en calciumkanalantagonist
ES2136443T3 (es) Limpieza in situ.
IT1305299B1 (it) Composizioni farmaceutiche a lento rilascio contenenti nifedipina,metodo per la preparazione delle stesse e relativo uso.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application